secwatch.observer — SEC 8-K summary
======================================

Issuer:     EKSO BIONICS HOLDINGS, INC. (CHRN)
CIK:        0001549084
Form:       8-K
Filed at:   2023-09-29T23:59:59+00:00
Accession:  0001437749-23-027198
Event type: regulatory
Sentiment:  negative
Materiality: 0.55
Item codes: 1.01, 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Ekso Bionics receives $700K from Parker-Hannifin; Nasdaq gives bid price deficiency notice
--------------------------------------------------------------------------------

- Received $700,000 from Parker-Hannifin in settlement of warranty obligations under Asset Purchase Agreement.
- Nasdaq notified Ekso that common stock bid price below $1.00 for 30 consecutive business days.
- Company has 180 days, until March 27, 2024, to regain compliance by closing at $1.00 for 10 consecutive days.
- If not compliant, may seek second 180-day period via reverse stock split or other cure.
- Notice has no immediate effect on listing; company intends to monitor and consider options.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1549084/000143774923027198/0001437749-23-027198-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1549084/000143774923027198/ekso20230929_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-23-027198

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer